Theratechnologies Receives Refusal to File Letter for Trogar

Theratechnologies Receives Refusal to File Letter for Trogarzo Intramuscular Method of Administration sBLA from FDA

27.02.2024 - MONTREAL, Feb. 27, 2024 (GLOBE NEWSWIRE) - Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today ... Seite 1

Related Keywords

Canada , United States , Christian Marsolais , Vice President , Chief Medical Officer , Chloride Injection ,

© 2025 Vimarsana